Prescribing newsletter June 2014

  • LMWH in high risk pregnancies
  • New MHRA advice for domperidone
  • Safety reminder – increased risk of suicidality with antidepressants and requirement for enhanced monitoring when doses are changed
  • Triptans and SSRI or SNRI – is there an interaction?
  • Interchangeability of oral mesalazine
  • Transfer of prescribing responsibility of specific inhaled drugs for the treatment of cystic fibrosis
  • Teriflunomide
  • NHS England repatriation of the prescribing of immunosuppressant therapies for organ transplant patients
  • Salazopyrin SPC update
  • Patient safety alert – Medicine Homecare Services
  • The safer management of controlled drugs